Extrawell Pharmaceutical Holdings Limited (HKG:0858)
0.0820
+0.0120 (17.14%)
Jul 13, 2026, 3:57 PM HKT
HKG:0858 Balance Sheet
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 89.51 | 77.77 | 93.61 | 102.4 | 111.88 |
Short-Term Investments | 1.77 | - | - | 0.75 | 0.74 |
Trading Asset Securities | 103.48 | 917.09 | 0.66 | 1.75 | 1.91 |
Cash & Short-Term Investments | 194.75 | 994.86 | 94.27 | 104.91 | 114.52 |
Cash Growth | -80.42% | 955.32% | -10.14% | -8.40% | -11.39% |
Accounts Receivable | 7.09 | 7.8 | 4.22 | 5.8 | 7.81 |
Other Receivables | 9.79 | 33.14 | 34.98 | 36.51 | 36.28 |
Receivables | 18.46 | 40.94 | 52.63 | 47.49 | 44.09 |
Inventory | 4.89 | 4.74 | 7.27 | 3.02 | 8.47 |
Prepaid Expenses | - | 1.14 | 1.13 | 2.54 | 1.4 |
Other Current Assets | 21.17 | 21.11 | 22.15 | 20.71 | 25.91 |
Total Current Assets | 239.28 | 1,063 | 177.44 | 178.66 | 194.38 |
Property, Plant & Equipment | 123.69 | 119.78 | 126.04 | 136.54 | 148.39 |
Long-Term Investments | 213.26 | 311.93 | 974.81 | 1,110 | 955.27 |
Goodwill | 1.81 | 1.81 | 1.81 | 1.81 | 1.81 |
Long-Term Deferred Tax Assets | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
Other Long-Term Assets | 2.15 | 2.28 | 2.42 | 2.55 | 2.68 |
Total Assets | 587.34 | 1,526 | 1,287 | 1,445 | 1,317 |
Accounts Payable | 3.96 | 4.43 | 4.66 | 6.63 | 6.46 |
Accrued Expenses | 23.03 | 17.7 | 19.7 | 21.49 | 24.08 |
Current Portion of Leases | 1.17 | 1.9 | 1.38 | 1.32 | 2.19 |
Current Income Taxes Payable | 11.31 | 19 | 18.1 | 16.43 | 17.2 |
Current Unearned Revenue | 0.12 | 3.16 | 5.36 | 6.61 | 6.87 |
Other Current Liabilities | - | 2.31 | 2.18 | 4.53 | 7.26 |
Total Current Liabilities | 39.59 | 48.5 | 51.37 | 57.01 | 64.06 |
Long-Term Debt | 165.05 | 139.04 | 117.12 | 98.62 | 83.07 |
Long-Term Leases | 3.11 | - | 1.91 | 3.29 | 0.04 |
Long-Term Unearned Revenue | 4.12 | 4.01 | 4.17 | 4.38 | 5 |
Total Liabilities | 211.87 | 191.55 | 174.58 | 163.3 | 152.18 |
Common Stock | 25.5 | 23.9 | 23.9 | 23.9 | 23.9 |
Additional Paid-In Capital | - | 196.58 | 196.58 | 196.58 | 196.58 |
Retained Earnings | - | 670.69 | 448.04 | 610.99 | 481.73 |
Comprehensive Income & Other | 349.59 | 443.38 | 444.61 | 450.25 | 463.45 |
Total Common Equity | 375.09 | 1,335 | 1,113 | 1,282 | 1,166 |
Minority Interest | 0.38 | 0.26 | -0.51 | -0.15 | -0.73 |
Shareholders' Equity | 375.47 | 1,335 | 1,113 | 1,282 | 1,165 |
Total Liabilities & Equity | 587.34 | 1,526 | 1,287 | 1,445 | 1,317 |
Total Debt | 169.33 | 140.94 | 120.41 | 103.22 | 85.31 |
Net Cash (Debt) | 25.42 | 853.92 | -26.14 | 1.68 | 29.22 |
Net Cash Growth | -97.02% | - | - | -94.24% | -47.23% |
Net Cash Per Share | 0.01 | 0.26 | -0.01 | 0.00 | 0.01 |
Filing Date Shares Outstanding | 2,550 | 2,390 | 2,390 | 2,390 | 2,390 |
Total Common Shares Outstanding | 2,550 | 2,390 | 2,390 | 2,390 | 2,390 |
Working Capital | 199.69 | 1,014 | 126.07 | 121.65 | 130.32 |
Book Value Per Share | 0.15 | 0.56 | 0.47 | 0.54 | 0.49 |
Tangible Book Value | 373.29 | 1,333 | 1,111 | 1,280 | 1,164 |
Tangible Book Value Per Share | 0.15 | 0.56 | 0.46 | 0.54 | 0.49 |
Buildings | - | 118.88 | 120.17 | 122.84 | 136.49 |
Machinery | - | 62.02 | 61.42 | 55.61 | 52.77 |
Construction In Progress | - | 0.46 | 0.09 | 6.01 | 7.89 |